請用此 Handle URI 來引用此文件:
http://tdr.lib.ntu.edu.tw/jspui/handle/123456789/8744
完整後設資料紀錄
DC 欄位 | 值 | 語言 |
---|---|---|
dc.contributor.advisor | 許金川(Jin-Chuan Sheu),高嘉宏(Jia-Horng Kao) | |
dc.contributor.author | Hsiao-Ching Nien | en |
dc.contributor.author | 粘曉菁 | zh_TW |
dc.date.accessioned | 2021-05-20T20:00:33Z | - |
dc.date.available | 2010-03-12 | |
dc.date.available | 2021-05-20T20:00:33Z | - |
dc.date.copyright | 2010-03-12 | |
dc.date.issued | 2010 | |
dc.date.submitted | 2010-02-03 | |
dc.identifier.citation | 參考文獻
1 Kao JH, Chen DS. Global control of hepatitis B virus infection. Lancet Infect Dis. 2002; 2(7):395-403. 2 Lee WM. Hepatitis B virus infection. N Engl J Med. 1997; 337(24):1733-45. 3 Beasley RP. Hepatitis B virus. The major etiology of hepatocellular carcinoma. Cancer. 1988; 61(10):1942-56. 4 Sorrell MF, Belongia EA, Costa J, et al. National Institutes of Health consensus development conference statement: management of hepatitis B. Hepatology. 2009; 49(5 Suppl):S4-S12. 5 Chen DS. Hepatitis C virus in chronic liver disease and hepatocellular carcinoma in Taiwan. Princess Takamatsu Symp. 1995; 25:27-32. 6 Chen DS. From hepatitis to hepatoma: lessons from type B viral hepatitis. Science. 1993; 262(5132):369-70. 7 Department of Health Taiwan. Cause of Death Statistics. Available at http://www.doh.gov.tw/. 2009. 8 Chen CH, Yang PM, Huang GT, Lee HS, Sung JL, Sheu JC. Estimation of seroprevalence of hepatitis B virus and hepatitis C virus in Taiwan from a large-scale survey of free hepatitis screening participants. J Formos Med Assoc. 2007; 106(2):148-55. 9 Chang MH, Chen CJ, Lai MS, et al. Universal hepatitis B vaccination in Taiwan and the incidence of hepatocellular carcinoma in children. Taiwan Childhood Hepatoma Study Group. N Engl J Med. 1997; 336(26):1855-9. 10 Ni YH, Chang MH, Huang LM, et al. Hepatitis B virus infection in children and adolescents in a hyperendemic area: 15 years after mass hepatitis B vaccination. Ann Intern Med. 2001; 135(9):796-800. 11 Chen CH, Su WW, Yang SS, et al. Long-term trends and geographic variations in the survival of patients with hepatocellular carcinoma: analysis of 11,312 patients in Taiwan. J Gastroenterol Hepatol. 2006; 21(10):1561-6. 12 Lin HH, Li YH, Yu JH, et al. Ethnic and geographic variations in the prevalence of hepatitis A, B and C among aboriginal villages in Hualien, Taiwan. Infection. 2000; 28(4):205-8. 13 Wang LY, Hu CT, Ho TY, Lin HH. Geographic and ethnic variations of long-term efficacy and immunogenicity of hepatitis B vaccination in Hualien, a HBV hyperendemic area. Vaccine. 2006; 24(20):4427-32. 14 Council of Indigenous Peoples Taiwan. Annual Statistic Report of Heath and Population in Taiwanese Aborigines in 2006 and 2007. Available at http://www.apc.gov.tw/. 2009. 15 Yu MW, Yeh SH, Chen PJ, et al. Hepatitis B virus genotype and DNA level and hepatocellular carcinoma: a prospective study in men. J Natl Cancer Inst. 2005; 97(4):265-72. 16 Chen JD, Liu CJ, Lee PH, et al. Hepatitis B genotypes correlate with tumor recurrence after curative resection of hepatocellular carcinoma. Clin Gastroenterol Hepatol. 2004; 2(1):64-71. 17 Kao JH, Chen PJ, Lai MY, Chen DS. Hepatitis B genotypes correlate with clinical outcomes in patients with chronic hepatitis B. Gastroenterology. 2000; 118(3):554-9. 18 Tseng TC, Liu CJ, Chen PJ, et al. Subgenotypes of hepatitis B virus genotype C do not correlate with disease progression of chronic hepatitis B in Taiwan. Liver Int. 2007; 27(7):983-8. 19 Liu CJ, Kao JH, Chen PJ, Lai MY, Chen DS. Molecular epidemiology of hepatitis B viral serotypes and genotypes in taiwan. Journal of biomedical science. 2002; 9(2):166-70. 20 Kao JH. Hepatitis B viral genotypes: clinical relevance and molecular characteristics. J Gastroenterol Hepatol. 2002; 17(6):643-50. 21 Iloeje UH, Yang HI, Jen CL, et al. Risk and predictors of mortality associated with chronic hepatitis B infection. Clin Gastroenterol Hepatol. 2007; 5(8):921-31. 22 Chen CJ, Iloeje UH, Yang HI. Long-Term Outcomes in Hepatitis B: The REVEAL-HBV Study. Clin Liver Dis. 2007; 11(4):797-816. 23 Huang YW, Lin CL, Chen PJ, Lai MY, Kao JH, Chen DS. Hepatitis B viral genotype in Taiwanese patients with acute hepatitis B. Hepatogastroenterology. 2008; 55(82-83):633-5. 24 Lin CL, Kao JH. Hepatitis B viral factors and clinical outcomes of chronic hepatitis B. Journal of biomedical science. 2008; 15(2):137-45. 25 Tseng TC, Kao JH. HBV genotype and clinical outcome of chronic hepatitis B: facts and puzzles. Gastroenterology. 2008; 134(4):1272-3; author reply 3. 26 Yang HI, Yeh SH, Chen PJ, et al. Associations between hepatitis B virus genotype and mutants and the risk of hepatocellular carcinoma. J Natl Cancer Inst. 2008; 100(16):1134-43. 27 Kao J-H. Role of viral factors in the natural course and therapy of chronic hepatitis B. Hepatol Int. 2007; 1:415–30. 28 Lau JY, Wright TL. Molecular virology and pathogenesis of hepatitis B. Lancet. 1993; 342(8883):1335-40. 29 Blumberg BS, Alter HJ, Visnich S. A 'New' Antigen in Leukemia Sera. Jama. 1965; 191:541-6. 30 Ou JH. Molecular biology of hepatitis B virus e antigen. J Gastroenterol Hepatol. 1997; 12(9-10):S178-87. 31 Tiollais P, Pourcel C, Dejean A. The hepatitis B virus. Nature. 1985; 317(6037):489-95. 32 Okamoto H, Imai M, Kametani M, Nakamura T, Mayumi M. Genomic heterogeneity of hepatitis B virus in a 54-year-old woman who contracted the infection through materno-fetal transmission. Jpn J Exp Med. 1987; 57(4):231-6. 33 Arauz-Ruiz P, Norder H, Robertson BH, Magnius LO. Genotype H: a new Amerindian genotype of hepatitis B virus revealed in Central America. J Gen Virol. 2002; 83(Pt 8):2059-73. 34 Norder H, Hammas B, Lofdahl S, Courouce AM, Magnius LO. Comparison of the amino acid sequences of nine different serotypes of hepatitis B surface antigen and genomic classification of the corresponding hepatitis B virus strains. J Gen Virol. 1992; 73 ( Pt 5):1201-8. 35 Kao JH, Chen PJ, Lai MY, Chen DS. Clinical and virological aspects of blood donors infected with hepatitis B virus genotypes B and C. Journal of clinical microbiology. 2002; 40(1):22-5. 36 Utsumi T, Yano Y, Truong BX, et al. Molecular epidemiological study of hepatitis B virus infection in two different ethnic populations from the Solomon Islands. J Med Virol. 2007; 79(3):229-35. 37 Tatematsu K, Tanaka Y, Kurbanov F, et al. A genetic variant of hepatitis B virus divergent from known human and ape genotypes isolated from a Japanese patient and provisionally assigned to new genotype J. J Virol. 2009; 83(20):10538-47. 38 Kao JH. Hepatitis B virus genotypes and hepatocellular carcinoma in Taiwan. Intervirology. 2003; 46(6):400-7. 39 Stevens CE, Beasley RP, Tsui J, Lee WC. Vertical transmission of hepatitis B antigen in Taiwan. N Engl J Med. 1975; 292(15):771-4. 40 Hsu HY, Chang MH, Chen DS, Lee CY, Sung JL. Baseline seroepidemiology of hepatitis B virus infection in children in Taipei, 1984: a study just before mass hepatitis B vaccination program in Taiwan. J Med Virol. 1986; 18(4):301-7. 41 Kao JH, Chen PJ, Lai MY, Chen DS. Hepatitis B virus genotypes and spontaneous hepatitis B e antigen seroconversion in Taiwanese hepatitis B carriers. Journal of medical virology. 2004; 72(3):363-9. 42 Liu CJ, Kao JH, Chen DS. Therapeutic implications of hepatitis B virus genotypes. Liver Int. 2005; 25(6):1097-107. 43 Ni YH, Chang MH, Wang KJ, et al. Clinical relevance of hepatitis B virus genotype in children with chronic infection and hepatocellular carcinoma. Gastroenterology. 2004; 127(6):1733-8. 44 徐富珍、陳信木. 蕃薯+芋頭=臺灣土豆?——臺灣當前族群認同狀況比較分析. 臺灣人口學會年會「人口、家庭與國民健康政策回顧與展望」研討會, 2004. 45 Department of Statistics of Ministry of the Interior Taiwan. Report on the Survey of Citizens' Life Status in Taiwan Area. Available at: http://www.moi.gov.tw/ 2002. 46 王明珂. 過去、集體記憶與族群認同:台灣的族群經驗,見中央研究院近代史研究所編,認同與國家:近代中西歷史的比較: 台北:中央研究院近代史研究所。 1994. 47 Council for Hakka Affairs Taiwan. General Investigation of Hakka Population in 2008. Available at http://www.hakka.gov.tw/. 2008. 48 王甫昌. 由「中國省籍」到「台灣族群」:戶口普查籍別類屬轉變之分析. 台灣社會學. 2005年6月; 第九期:59-117. 49 李壬癸. 台灣南島民族的族群與遷徙: 台北:常民文化 1997. 50 王嵩山. 臺灣原住民社會與文化概論: 台北:聯經 2001. 51 Council of Indigenous Peoples Taiwan. Statistic Report in Taiwan Aborigines in 2002. Available at http://wwwapcgovtw/. 2002. 52 黃宣範. 臺灣:南島民族最可能的原鄉. 臺大校友雙月刊. 2009; 64:6-14. 53 林媽利. 從DNA 的研究看台灣原住民的來源. LANGUAGE AND LINGUISTICS. 2001; 2(1):241-6. 54 Sakugawa H, Nakasone H, Nakayoshi T, et al. Preponderance of hepatitis B virus genotype B contributes to a better prognosis of chronic HBV infection in Okinawa, Japan. J Med Virol. 2002; 67(4):484-9. 55 Liu Y, Hussain M, Wong S, Fung SK, Yim HJ, Lok AS. A genotype-independent real-time PCR assay for quantification of hepatitis B virus DNA. J Clin Microbiol. 2007; 45(2):553-8. 56 Chen J, Yin J, Tan X, et al. Improved multiplex-PCR to identify hepatitis B virus genotypes A-F and subgenotypes B1, B2, C1 and C2. J Clin Virol. 2007; 38(3):238-43. 57 Kirschberg O, Schuttler C, Repp R, Schaefer S. A multiplex-PCR to identify hepatitis B virus--enotypes A-F. J Clin Virol. 2004; 29(1):39-43. 58 Naito H, Hayashi S, Abe K. Rapid and specific genotyping system for hepatitis B virus corresponding to six major genotypes by PCR using type-specific primers. J Clin Microbiol. 2001; 39(1):362-4. 59 Gunther S, Li BC, Miska S, Kruger DH, Meisel H, Will H. A novel method for efficient amplification of whole hepatitis B virus genomes permits rapid functional analysis and reveals deletion mutants in immunosuppressed patients. J Virol. 1995; 69(9):5437-44. 60 Tai DI, Changchien CS, Hung CS, Chen CJ. Replication of hepatitis B virus in first-degree relatives of patients with hepatocellular carcinoma. Am J Trop Med Hyg. 1999; 61(5):716-9. 61 Liaw YF, Leung N, Kao JH, et al. Asian-Pacific consensus statement on the management of chronic hepatitis B: a 2008 update. Hepatol Int. 2008; 2(3):263-83. | |
dc.identifier.uri | http://tdr.lib.ntu.edu.tw/jspui/handle/123456789/8744 | - |
dc.description.abstract | 一、研究背景及目的
B型肝炎是台灣引起肝癌的最主要原因,然而根據統計,台灣原住民之慢性肝病及肝硬化死亡率雖然遠高於非原住民族群,但肝癌死亡率卻略低於非原住民。此外,偏遠地區之肝癌存活率也較一般都會地區為低。台灣B型肝炎病毒基因型主要為B型及C型,其中基因型B盛行率高達80%,一但隨著肝炎、肝硬化及肝癌的進展,基因型B型之盛行率也逐漸下降;另外,B型肝炎之病毒量偏高與e抗原陽性者,其未來罹患肝癌風險也較高。本研究以台灣偏遠地區居民及原住民為對象,探討一般社區族群之B型肝炎患者,其影響未來罹患肝癌之因子與病毒基因型分佈,是否存在地區性與不同族群間之差異。 二、研究方法 針對台灣偏遠地區成年B型肝炎患者,進行基本資料收集、問卷、抽血檢查(包括:AST、ALT、AFP、e抗原及抗體、病毒量、基因型)及腹部超音波檢查。以即時聚合酶鏈反應法(Real-Time polymerase chain reaction)技術先進行B型肝炎病毒量(HBV DNA level)檢測,以巢式聚合酶鏈反應法(nested polymerase chain reaction) 和多重聚合酵素鏈鎖反應(multiplex-polymerase chain reaction)技術檢定病毒基因型,再來分析病毒全長基因體定序以確定基因型之正確性。最後以不同的統計方法分析所收集之資料結果。 三、研究結果 研究中招募3,488位(1,527位原住民與1,961位非原住民)來自台灣各地偏遠社區的B型肝炎患者,原住民相較於非原住民族群之下,兩者平均年齡約50歲且平均ALT為39 U/L,統計上並無明顯差異;而統計上顯著發現者為:其e抗原陽性率較低(5.3% vs. 10.2%,p-value<0.0001)、HBV DNA>2, 000 IU/ml比率也較低(27.4% vs. 36.7%,p-value<0.0001)、有經常飲酒習慣者比率則較高(40.0% vs. 19.3%,p-value<0.0001)。取其中有基因型分析結果之1,178人,發現任何年齡層之原住民基因型B/C盛行率皆偏高(92.7% vs. 72.7%,p-value<0.05)且以鄒族語系與排灣語系為最高(97%)。而離島地區(澎湖縣與連江縣)非原住民的B型肝炎患者以基因型C為主(60%),本島地區以基因型B為主(89%)。此外,研究中發現13位在台灣相當罕見的基因型D,主要集中於屏東縣,以當地排灣族居多,其病毒量較高(HBV DNA >2,000 IU/ml),且問卷資料顯示雖有部分病患曾經接受輸血、開刀、刺青或穿體洞,但無人曾共用針頭。 四、結論 本研究發現影響罹患肝癌風險的因子,如:B型肝炎病毒之病毒量、e抗原陽性率及基因型C盛行率等,屬於南島語族的原住民都較非原住民族群為低。由此可知B型肝炎並非主要造成原住民慢性肝病死亡率較高的原因,可能是酒精性肝炎或其他原因所導致。另外,某些地區群聚台灣較為罕見之B型肝炎病毒基因型D,其感染途徑與傳播方式,未來都值得進一步研究與調查。 | zh_TW |
dc.description.abstract | Background:
Hepatitis B virus (HBV) infection is the major cause of hepatocellular carcinoma (HCC) in Taiwan. The standardized mortality rates of chronic liver diseases and liver cirrhosis are higher in Taiwanese aborigines than non-aborigines. However, the standardized mortality rate of HCC is slightly lower in Taiwanese aborigines. High HBV DNA, positive HBeAg and genotype C have been shown be the risks for the HBV-related HCC. Therefore, in this study we further investigated the distributions of HCC related risk factors in HBV patients and HBV genotype among different regional areas and ethnic groups. Materials and methods: A total of 3,488 patients (1,527 aborigines and 1,961 non-aborigines) with HBV infection were recruited from various regions in Taiwan. Basic background information and blood samples were collected and abdominal ultrasound examinations were done. The blood samples were checked for AST, ALT, AFP, HBeAg, anti-HBe, HBV DNA by Real-Time PCR (polymerase chain reaction, PCR) and genotype by nested PCR (nested polymerase chain reaction) and multiplex-PCR (multiplex-polymerase chain reaction). The accuracy of HBV genotypes was validated with full length sequence. Results: There were no differences in the mean age (50 years old) and mean ALT levels (39 U/L) between aborigines and non-aborigines. However, lower HBeAg-positive rate (5.3% vs. 10.2%, p<0.0001), lower rate of HBV DNA > 2,000 IU/ml (27.4% vs. 36.7%, p<0.0001), higher rate of drinking habit(40.0% vs. 19.3%, p<0.0001)were noted in aborigines than non-aborigines. Among 1,178 patients with complete data of genotype and HBeAg, the prevalence of genotype B in aborigine group was higher (92.7%) than that in non-aborigine group (72.7%) in any age group (p<0.05), especially in Tsou (97%). The dominant genotype was C in non-aborigines in Penghu County and Lienchiang County (60%) and was genotype B in the countries of Taiwan island (89%). Besides, our research found 13 patients with genotype D, a very rare genotype in Taiwan. Patients with genotype D were clustered in the local Paiwan tribe of Pingtung County. These subjects had higher HBV DNA (greater than 2,000 IU/ml) without the experience of sharing needles with others and some of them had received blood transfusion or surgeries or tattoo or piercings. Conclusion: We found Taiwanese aborigines who belong to Austronesian language populations have lower HBV DNA viral load, lower HBeAg-positive rate and higher prevalence of HBV genotype B when compared with non-aborigines. Therefore, HBV infection is not the major cause of the death of chronic liver diseases in Taiwanese aborigines. A cluster of patients with HBV genotype D was found in the local area of southern Taiwan. | en |
dc.description.provenance | Made available in DSpace on 2021-05-20T20:00:33Z (GMT). No. of bitstreams: 1 ntu-99-P96421007-1.pdf: 1423149 bytes, checksum: 16a10b8a031e2a1f4dd57323de974e2c (MD5) Previous issue date: 2010 | en |
dc.description.tableofcontents | 目 錄
口試委員會審定書 .……………………………….……………………..…………i 誌謝 ……………………………………………………………………………...…….ii 中文摘要 ……………………………………………….…………………...…..…….v 英文摘要 ………………………………………………..……………………….….vii 目錄 ………………………………………………………..……………….………….x 圖目錄 ……………………………………………………………………………….xii 表目錄及附件…………..…………………………………………………………..xiii 緒論……………………………………………………………………………………..1 第一章:背景及詳細的文獻回顧 ...............................................................................1 第一節:台灣B型肝炎在非原住民與原住民的角色..............................................1 第二節:B型肝炎病毒介紹......................................................................................2 第三節:B型肝炎病毒之基因型分佈與其相關病況..............................................3 第四節:台灣地區之族群簡介.................................................................................5 第二章、欲研究的問題及其重要性 ...........................................................................7 第一節:偏遠地區及原住民B型肝炎患者概況 ....................................................7 第二節:B型肝炎病毒之基因型於不同族群之分佈..............................................8 第三章、研究的假說與特定目的 ...............................................................................9 研究方法與材料…………………………………………………………………….10 第一章:受試者選擇標準...........................................................................................10 第二章:研究設計與流程...........................................................................................11 第一節:研究活動設計...........................................................................................11 第二節:研究活動流程...........................................................................................11 第三節:檢體分析方法...........................................................................................12 第三章:統計方法.......................................................................................................14 研究結果.......................................................................................................................16 第一章:基本資料及抽血資料結果分析...................................................................16 第二章:基因型B及C之結果分析...........................................................................18 第三章:非原住民與原住民族群間基因型B及C之結果分析 .............................19 第四章:基因型D之結果分析基本資料及抽血資料結果分析...............................20 討論................................................................................................................................21 未來展望.......................................................................................................................25 英文論文簡述.............................................................................................................27 Introduction.................................................................................................................27 Methods.......................................................................................................................36 Results.........................................................................................................................42 Discussions.................................................................................................................50 Future Prospects .........................................................................................................56 參考文獻.......................................................................................................................59 附錄................................................................................................................................64 圖目錄 圖 1. B型肝炎病毒結構 ……………………………………………..…………….…64 圖 2. B型肝炎病毒之DNA結構 ……………………………………..……………....65 圖 3. B型肝炎病毒之主要基因型世界分佈圖 ……………………………………...66 圖 4. 南島語族之世界分佈 …………………………………………………………67 圖 5. 問卷內容 ………………………………………………………………………68 圖 6. 研究活動流程 …………………………………………………………………69 圖 7. B型肝炎病毒六種基因型之電泳圖………………………………………….70 圖 8. 不同年齡層非原住民與原住民之基因型B盛行率……………………………71 表目錄及附件 表 1. 判定B型肝炎病毒基因型所用之Nested PCR及multiplex-PCR之引子…...….72 表 2. B型肝炎病毒全長基因體定序之引子…...…………………..............................73 表 3. B型肝炎受試者之基本資料及抽血資料 …………………………….………..74 表 4. 基因型B或C之B型肝炎受試者基本資料及抽血資料 ………………………75 表 5. 非原住民與原住民不同基因型與e抗原狀態之比較 ………………………..76 表 6. 四大原住民語系不同基因型與e抗原狀態之比較 …………………………..77 表 7. 基因型D者之基本資料及抽血資料 ………………………………………….78 附件 1. 受試者同意書………………………………………………………………..79 | |
dc.language.iso | zh-TW | |
dc.title | 台灣偏遠地區居民及原住民B型肝炎之研究 | zh_TW |
dc.title | Investigation of Hepatitis B in Residents of Rural Areas and Aborigines in Taiwan | en |
dc.type | Thesis | |
dc.date.schoolyear | 98-1 | |
dc.description.degree | 碩士 | |
dc.contributor.oralexamcommittee | 吳肇卿(Jaw-Ching Wu),莊萬龍(Wang-Long Chuang),張美惠(Mei-Hwei Chang) | |
dc.subject.keyword | 台灣偏遠地區,原住民,B型肝炎,基因型,病毒量,e抗原陽性率,南島語族, | zh_TW |
dc.subject.keyword | Taiwanese rural areas,aborigine,hepatitis B virus (HBV),genotype,HBV DNA,HBeAg-positive rate,Austronesian language populations, | en |
dc.relation.page | 82 | |
dc.rights.note | 同意授權(全球公開) | |
dc.date.accepted | 2010-02-03 | |
dc.contributor.author-college | 醫學院 | zh_TW |
dc.contributor.author-dept | 臨床醫學研究所 | zh_TW |
顯示於系所單位: | 臨床醫學研究所 |
文件中的檔案:
檔案 | 大小 | 格式 | |
---|---|---|---|
ntu-99-1.pdf | 1.39 MB | Adobe PDF | 檢視/開啟 |
系統中的文件,除了特別指名其著作權條款之外,均受到著作權保護,並且保留所有的權利。